Melanoma Research

Skip Navigation LinksHome > August 2014 - Volume 24 - Issue 4 > Contributor Index

August 2014 - Volume 24 - Issue 4 - Contributor Index

View All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Other
Actions
View
Show
Previous of 2 Next
Author Name Article
Alrwas, Anas

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Arkenau, Hendrik-Tobias

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Asgari, Maryam M.

Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Astanehe, Arezoo

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Atkinson, Victoria G.

Response rate to vemurafenib in patients with B-RAF-positive melanoma brain metastases: a retrospective review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Babovic, Nada Lj.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bassett, Roland Jr

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Battistella, Maxime

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Becker, Nils

Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Bedikian, Agop Y.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Berthod, Gregoire

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Boubaker, Ariane

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Branicki, Wojciech

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Brice, Pauline

Four cases of rituximab-associated melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Cain, Suzanne

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chan, Hee-Lam

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chen, Guilin

Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Chin, Melvin

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Colman, Matthew W.

Does metastasectomy improve survival in skeletal melanoma?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Commandeur, Suzan

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Džodic, Radan R.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Davies, Michael A.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
de Leval, Laurence

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Deburr, Tawania L.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dehner, Louis P.

Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Demartines, Nicolas

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dennis, Mike

Vemurafenib-induced nonautoimmune haemolytic anaemia

Purchase Access
PDF
+ Favorites
Request Permissions
di Maggio, Antonio

Neoadjuvant treatment with dabrafenib of unresectable localizations from occult melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Du, Ziwei

Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dulmage, Brittany O.

Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Dzienis, Marcin R.

Response rate to vemurafenib in patients with B-RAF-positive melanoma brain metastases: a retrospective review

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Eide, Melody J.

Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
el Ghalbzouri, Abdoelwaheb

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Falo, Louis D. Jr.

Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fang, Zhengyu

Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fletcher, Suzanne W.

Comparing characteristics of melanoma cases arising in health maintenance organizations with state and national registries

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Fusi, Alberto

Vemurafenib-induced nonautoimmune haemolytic anaemia

Purchase Access
PDF
+ Favorites
Request Permissions
Gao, Linda

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gero, Daniel

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Geskin, Larisa J.

Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Goodman, Mark A.

Does metastasectomy improve survival in skeletal melanoma?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gru, Alejandro A.

Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gruis, Nelleke A.

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Gutkina, Nadezhda

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Haiducu, Marius L.

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Halaban, Ruth

Rare SF3B1 R625 mutations in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hao, Yinghua

Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hartmann, Arndt

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
He, Yanling

Potential roles of abnormally expressed long noncoding RNA UCA1 and Malat-1 in metastasis of melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Heinzerling, Lucie

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hinek, Anna

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Ho, Jonhan

Comparative proteomic analysis reveals unique tumor protein composition among the melanoma subtypes pure desmoplastic and superficial spreading

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hodgetts, Jackie

Vemurafenib-induced nonautoimmune haemolytic anaemia

Purchase Access
PDF
+ Favorites
Request Permissions
How-Kit, Alexandre

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Hwu, Patrick

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Hwu, Wen-Jen

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Jamal, Sumayah

Akt and PI3K-dependent but CREB-independent upregulation of MCAM by endothelin-3 in human melanocytes

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Jurišic, Vladimir B.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kalia, Sunil

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kim, Kevin B.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kirkwood, John M.

Does metastasectomy improve survival in skeletal melanoma?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kong, Yong

Rare SF3B1 R625 mutations in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Konjevic, Gordana M.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kosiniak-Kamysz, Agnieszka

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kovalenko, Sergei

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Krauthammer, Michael

Rare SF3B1 R625 mutations in cutaneous melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Kuehnapfel, Sarah

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lebbé, Celeste

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Lebbé, Céleste

Four cases of rituximab-associated melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lee, Tim K.

Extracutaneous melanoma epidemiology in British Columbia

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Li, Bin

Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Li, Yanyan

Comparative analysis of pathology and boronophenylalanine uptake in experimental orthotopic and heterotopic amelanotic melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Lorigan, Paul

Vemurafenib-induced nonautoimmune haemolytic anaemia

Purchase Access
PDF
+ Favorites
Request Permissions
Lyubchenko, Lyudmila

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Mak, Gabriel

Resistance surveillance in a BRAF mutant melanoma patient on long-term BRAF-inhibitor treatment

Open Access
Abstract
PDF
+ Favorites
Request Permissions
Marcinska, Magdalena

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Marczakiewicz-Lustig, Anna

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Matter, Maurice

Accuracy of sentinel lymph node dissection for melanoma staging in the presence of a collision tumour with a lymphoproliferative disease

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
McGough, Richard L. III

Does metastasectomy improve survival in skeletal melanoma?

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Mirjacic Martinovic, Katarina M.

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Mourah, Samia

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Osio, Amélie

Four cases of rituximab-associated melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Out, Jacoba J.

In-vitro melanoma models: invasive growth is determined by dermal matrix and basement membrane

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Pages, Cécile

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Pagès, Cécile

Four cases of rituximab-associated melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Papadopoulos, Nicholas E.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Patel, Sapna P.

Phase I trial of biochemotherapy with cisplatin, temozolomide, and dose escalation of nab-paclitaxel combined with interleukin-2 and interferon-α in patients with metastatic...

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Pfeifer, John D.

Mucosal melanoma: correlation of clinicopathologic, prognostic, and molecular features

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Pigozzo, Jacopo

Neoadjuvant treatment with dabrafenib of unresectable localizations from occult melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Pisareva, Ekaterina

Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions
Podgorniak, Marie-Pierre

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Porcher, Raphael

BRAFV600 mutation levels predict response to vemurafenib in metastatic melanoma

Purchase Access
PDF
+ Favorites
Request Permissions
Pospiech, Ewelina

Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects